THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Drug-coated stents may be losing favor

By Stephen Heuser
Globe Staff / October 18, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

After a three-year run in which drug-coated stents grew into one of the most profitable, fastest-selling medical devices in history, doctors now appear to be using fewer of them -- a change that could hurt local life-science giant Boston Scientific Corp. (Full article: 580 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly